Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
INSIGHT PROVIDER
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Message
Follow
Location:
India
Joined:
30 September 2021
668
Insights
249.5k
Views
217
Followers
Health Care
•
Equity Bottom-Up
•
Thematic (Sector/Industry)
Message
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
Samsung Biologics
•
02 Jul 2024 20:12
Samsung Biologics (207940 KS): Gaining Momentum on New Approval and Contract Wins; Hold Shares
Samsung Biologics signs $1.1B CMO contract, representing 40% of 2023 revenue. Samsung Bioepis receives FDA approval for Stelara biosimilar...
Tina Banerjee
116 Views
Share
bullish
•
SK Bioscience
•
30 Jun 2024 01:51
SK Bioscience (302440 KS): Acquiring Majority Stake in IDT Biologika- A Step Toward ‘Globalization’
SK Bioscience secures 60% stake in IDT Biologika, a global CDMO company with state-of-the-art manufacturing facilities in Germany, for KRW339B...
Tina Banerjee
317 Views
Share
bearish
•
Emcure Pharmaceuticals
•
28 Jun 2024 22:24
Emcure Pharmaceuticals Pre-IPO: IPO Price Band Set; Steep Valuation Offers Limited Upside Potential
Emcure Pharmaceuticals seeks to raise INR19.5B through fresh issue of INR8B and an OFS of 11.4M shares. The issue will open for subscription on...
Tina Banerjee
458 Views
Share
bullish
•
Dr. Reddy's Laboratories
•
27 Jun 2024 22:00
Dr. Reddy's Laboratories (DRRD IN): Nicotinell Acquisition to Fortify Consumer Healthcare Business
Dr. Reddy's is acquiring Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy outside US for £500M ($633M)....
Tina Banerjee
257 Views
Share
bullish
•
Otsuka Holdings
•
26 Jun 2024 21:31
Otsuka Holdings (4578 JP): Label Expansion of Rexulti; 1H24 Guidance Revision; New Mid-Term Plan
Otsuka's top selling drug Rxulti is expected to get FDA approval for a new indication in early 2025. The company has reduced profit guidance for...
Tina Banerjee
237 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x